SEC Reopens Review of Nasdaq Bitcoin Options Approval After CME Group Petition
Key Takeaways
- •The SEC granted CME Group's request to review its earlier approval of Nasdaq's Bitcoin options proposal, pausing implementation without invalidating the original decision.
- •CME Group argued that the SEC's authorization of Nasdaq's Bitcoin options conflicted with established market structure principles and created competitive fairness concerns.
- •CME currently operates as the sole U.S. platform for Bitcoin options under CFTC oversight, while Nasdaq's proposed product would be tied to spot ETF shares and fall under SEC securities-market regulation.
- •The SEC has invited public comments from market stakeholders through August 24, 2026, before determining whether to uphold, alter, or rescind the approval.
- •The review proceeding is being closely watched as a potential signal of the SEC's stance on additional exchange-traded crypto derivatives products going forward.
The U.S. Securities and Exchange Commission has granted CME Group's request for a review of the SEC's prior approval of Nasdaq's proposal to list and trade Bitcoin options, placing the initiative on hold pending further examination. The SEC has simultaneously invited public comments, with written opinions due no later than August 24, 2026.
Background: How the Dispute Unfolded
Nasdaq had initially received SEC approval to launch options tied to its Bitcoin spot ETFs. CME Group — the largest U.S. derivatives exchange — subsequently filed a petition arguing that the authorization conflicted with established market structure principles and raised concerns about competitive fairness.
The SEC's decision to grant the review does not invalidate the original approval, but it does pause the implementation process while the Commission reevaluates the submission.
Significance for Crypto Derivatives Markets
Bitcoin options are regulated financial instruments that allow hedge funds and other institutional participants to hedge against Bitcoin price risk and manage volatility. These products are viewed as a complement to Bitcoin spot ETFs, which have attracted substantial inflows since their launch in early 2024.
SEC grants CME petition for review of Nasdaq Bitcoin options approval; parties may submit comments by August 24. pic.twitter.com/iZE2DQYp4o — MSB Intel (@MSBIntel) August 1, 2026
SEC grants CME petition for review of Nasdaq Bitcoin options approval; parties may submit comments by August 24. pic.twitter.com/iZE2DQYp4o
If Nasdaq proceeds with listing Bitcoin options on its venue, CME would no longer be the sole U.S. platform for trading Bitcoin options. CME currently lists Bitcoin futures and options on Bitcoin futures under Commodity Futures Trading Commission oversight, whereas Nasdaq's proposed options would tied to spot ETF shares and fall under SEC securities-market regulation. The competitive tension between the two regulatory frameworks is a defining feature of how crypto derivatives are being integrated into the U.S. financial system, and the dispute underscores the growing recognition among traditional exchanges of the significant potential in this expanding market.
Stakeholder Opportunities and Regulatory Path Forward
The comment period running through August 24 provides a window for various market stakeholders — including exchanges, funds, and custodial providers — to submit their perspectives to the SEC.
Following the close of the comment period, the SEC will determine whether to maintain, modify, or withdraw the approval. The proceeding is part of a broader regulatory landscape in which authorities continue to integrate new crypto products into the market framework, building on successful ETF launches and ongoing stablecoin regulatory developments. Similar SEC review processes have shaped the rollout of other crypto-linked securities products, and market participants are closely watching whether the agency's approach here signals its stance on additional exchange-traded crypto derivatives going forward.